Related Experiment Video
Updated: May 22, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
Kim Forrester-Dumont1, Ovidiu Galescu, Andrey Kolesnikov
1Division of Adolescent Medicine, The Children's Hospital at SUNY Downstate, Brooklyn, NY, USA.
International Journal of Endocrinology
|April 27, 2012
Summary
In adolescent girls with polycystic ovarian syndrome (PCOS), high testosterone levels did not worsen metabolic syndrome risk factors. Insulin resistance and obesity, not hyperandrogenism, are key concerns for metabolic health in PCOS.
Area of Science:
- Endocrinology
- Reproductive Health
- Metabolic Disorders
Background:
- Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and obesity in adolescents.
- The specific impact of hyperandrogenism on metabolic syndrome development in PCOS remains unclear.
- Understanding these factors is crucial for managing adolescent PCOS and preventing long-term health issues.
Purpose of the Study:
- To investigate the role of hyperandrogenism in the development of metabolic syndrome in adolescent girls with PCOS.
- To determine if testosterone levels influence metabolic parameters associated with metabolic syndrome.
- To differentiate the effects of obesity versus hyperandrogenism on metabolic health in this population.
Main Methods:
- A cohort of 107 adolescent girls was studied, with 54 diagnosed with PCOS.
- Data collected included blood pressure, BMI, testosterone, LH, FSH, prolactin, lipids, and glucose.
- PCOS participants were categorized into subgroups based on BMI and testosterone levels (High Testosterone, Intermediate Testosterone, Obese Normal Testosterone, Control).
Main Results:
- No significant differences in systolic blood pressure, diastolic blood pressure, fasting glucose, or lipid profiles were observed between PCOS subgroups with varying testosterone levels.
- The control group exhibited lower systolic blood pressure and BMI compared to obese and hyperandrogenic PCOS groups.
- Hormonal levels (LH, FSH, prolactin) did not differ significantly across the PCOS subgroups.
Conclusions:
- Hyperandrogenism, regardless of its level, does not appear to negatively impact the metabolic profile of adolescent girls with PCOS.
- Insulin resistance and obesity are more significant contributors to metabolic disturbances in adolescent PCOS than elevated androgens.
- These findings suggest that management strategies for metabolic syndrome in adolescent PCOS should prioritize addressing obesity and insulin resistance.
Related Concept Videos
01:27Signs of Puberty
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:29The Endocrine System
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...